Valuation: Merck KGaA

Capitalization 49.13B 57.51B 45.3B 42.75B 79.44B 5,385B 81.46B 531B 209B 2,572B 216B 211B 9,186B P/E ratio 2026 *
18.8x
P/E ratio 2027 * 16.1x
Enterprise value 56.22B 65.8B 51.83B 48.91B 90.9B 6,162B 93.2B 607B 239B 2,943B 247B 242B 10,511B EV / Sales 2026 *
2.68x
EV / Sales 2027 * 2.46x
Free-Float
29.72%
Yield 2026 *
2.1%
Yield 2027 * 2.19%
1 day+3.03%
1 week+8.52%
Current month+8.27%
1 month+7.67%
3 months-8.27%
6 months+1.00%
Current year-4.98%
1 week 110.25
Extreme 110.25
116.5
1 month 100.7
Extreme 100.7
116.5
Current year 100.7
Extreme 100.7
131.65
1 year 100.7
Extreme 100.7
131.65
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2021
Director of Finance/CFO 55 01/07/2023
Chief Tech/Sci/R&D Officer - 01/07/2021
Director TitleAgeSince
Director/Board Member - 26/04/2019
Director/Board Member 63 01/05/2012
Director/Board Member 77 09/05/2014
Change 5d. change 1-year change 3-years change Capi.($)
+2.94%+8.52%-0.89%-29.14% 57.51B
-0.16%-6.22%+16.17%-19.61% 8.19B
+0.72%+6.25%+10.07%+89.55% 7.94B
+0.20%+3.03%-3.33%+29.53% 5.2B
-0.86%+0.33%-16.04%+63.35% 4.6B
+1.70%-0.13%+61.06%+41.14% 2.88B
-1.47%-1.31%-14.27%-38.34% 2.69B
-0.66%+3.62%+29.14%+36.60% 2.45B
-5.48%-6.74%-2.67%-23.98% 1.93B
-1.12%+0.30%+78.91%-3.49% 1.94B
Average -0.42%+0.39%+15.81%+14.56% 9.53B
Weighted average by Cap. +1.70%+1.96%+4.47%-6.59%

Financials

2026 *2027 *
Net sales 20.99B 24.57B 19.35B 18.26B 33.94B 2,301B 34.8B 227B 89.12B 1,099B 92.2B 90.25B 3,924B 22.03B 25.79B 20.32B 19.17B 35.63B 2,415B 36.53B 238B 93.55B 1,153B 96.79B 94.74B 4,120B
Net income 2.62B 3.06B 2.41B 2.28B 4.23B 287B 4.34B 28.25B 11.11B 137B 11.49B 11.25B 489B 3.02B 3.54B 2.79B 2.63B 4.89B 331B 5.01B 32.64B 12.83B 158B 13.28B 13B 565B
Net Debt 7.09B 8.29B 6.53B 6.17B 11.46B 777B 11.75B 76.52B 30.08B 371B 31.13B 30.47B 1,325B 5.02B 5.87B 4.63B 4.37B 8.11B 550B 8.32B 54.2B 21.31B 263B 22.05B 21.58B 938B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
59,077
Date Price Change Volume
14/04/26 116.60 +3.19% 165,142
13/04/26 113.00 +1.03% 203,319
10/04/26 111.85 +0.40% 240,768
09/04/26 111.40 -1.33% 271,623
08/04/26 112.90 +5.17% 418,847
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
113.00EUR
Average target price
141.67EUR
Spread / Average Target
+25.37%

Quarterly revenue - Rate of surprise